Milnacipran-Associated Urinary Retention A Case Report

被引：4
作者：
Aggarwal, Ashish [1 ]
Khandelwal, Ashish [1 ]
Jiloha, Ram C. [1 ]
机构：
[1] GB Pant Hosp, Dept Psychiat, New Delhi, India
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2010年 / 30卷 / 05期
关键词：
TOLERABILITY; EFFICACY;
D O I：
10.1097/JCP.0b013e3181f05822
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：641 / 641
页数：1
相关论文
共 4 条
  • [1] Tamsulosin as an effective treatment for reboxetine-associated urinary hesitancy
    Demyttenaere, K
    Huygens, R
    Van Buggenhout, R
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (06) : 353 - 355
  • [2] Efficacy and tolerability of milnacipran: An overview
    Montgomery, SA
    Prost, JF
    Solles, A
    Briley, M
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 : 47 - 51
  • [3] A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS
    NARANJO, CA
    BUSTO, U
    SELLERS, EM
    SANDOR, P
    RUIZ, I
    ROBERTS, EA
    JANECEK, E
    DOMECQ, C
    GREENBLATT, DJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) : 239 - 245
  • [4] SNRIs: The pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants
    Stahl, SM
    Grady, MM
    Moret, C
    Briley, M
    [J]. CNS SPECTRUMS, 2005, 10 (09) : 732 - 747
1